Lobular Carcinoma in Situ (LCIS) is a pre-cancerous condition that usually affects women aged between 40 and 50 before menopause. LCIS is not a cancer. However, women with LCIS in one or both breasts are much more likely to develop breast cancer in either breast. Abnormal cell growth in the lobules (the milk-producing lobes) indicate a higher risk of developing invasive breast cancer. Generally, people with LCIS have more than one affected area, or lobule. Alternative Cancer Treatment Mexico offers Lobular Carcinoma in Situ treatment to help minimize your chances.
Because LCIS does not show up on a mammogram or present with any symptoms, it is not certain how many women have the condition before developing cancer, or without ever developing breast cancer. Lobular Carcinoma in Situ treatment does not require conventional cancer treatment, as it is has not yet become a cancer. Close observation, lifestyle changes and sometimes preventative drugs are administered to help minimize the chances of the condition developing into breast cancer.
Our Functional Oncology program is tailored to each individual and their condition. We are able to optimize an LCIS patient’s cellular health, using nutrition and lifestyle changes to help a person with LCIS to stay healthy. Our programs are designed to fight cancerous cells, regulate cell growth and provide immunity support. With the help of non-invasive treatment that combines the very best of modern and traditional medicine, the Functional Oncology Program from Alternative Cancer Treatment Mexico will help to make sure that you can minimize the chances of your LCIS developing into invasive breast cancer.
To speak to a cancer consultant today, please contact our functional oncology team by filling out an inquiry form today.